MN/CA IX/ CA9 and renal cancer prognosis

Details for Australian Patent Application No. 2005241093 (hide)

Owner Institute of Virology of Slovak Academy of Sciences

Inventors Erdogan, Seyda; Soyupak, Bulent

Agent Spruson & Ferguson

Pub. Number AU-B-2005241093

PCT Pub. Number WO2005/108623

Priority 60/568,019 04.05.04 US

Filing date 4 May 2005

Wipo publication date 17 November 2005

Acceptance publication date 5 June 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/108623 Priority application(s): WO2005/108623

25 October 2007 Change of Name(s) of Applicant(s), Section 104

  Bayer Healthcare The name of the applicant has been changed to Institute of Virology of Slovak Academy of Sciences

5 June 2008 Application Accepted

  Published as AU-B-2005241093

2 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005241094-Improved lubrication in a transmission

2005241090-Interlaced series parallel configuration for metal solvent extraction plants